Author:
Nibbering P. H.,Bezemer A. C.,van de Gevel J. S.,Zomerdijk T. P. L.,Langermans J. A. M.,van Furth R.
Reference58 articles.
1. Murray HW. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med 1988, 108:595–608.
2. Nathan CF. Secretory products of macrophages. J Clin Invest 1987, 79:319–326.
3. Mackeness GB. Resistance to intracellular infection. J Infect Dis 1971, 123:439–445.
4. Van Dissel JT, Stikkelbroeck JJM, van den Barselaar MTh, Sluiter W, Leijh PCJ, van Furth R. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages. J Immunol 1987, 139:1665–1672.
5. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991, 49:380–387.